原标题:百济神州、和黄医药、亚盛医药、诺诚健华等创新产品即将亮相 来源:药明康德官微第62届美国血液学会()年会将于2020年12月5至8日举行。根据ASH年会摘要及公开资料,来自、、亚盛医药、诺诚健华、亘喜生物、等中国公司的众多创新疗法也即将在本次大会上亮相。这些产品包括BTK抑制剂、PD-1单抗、PI3Kδ抑制剂、BCR-ABL抑制剂、双靶向CAR-T疗法等等。今日,我们将节选部分即将亮相...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.